Skip to content
Sign in

VIR · NASDAQ

Vir Biotechnology (VIR) Stock Price & Fundamentals

$585.35+1.29%+$7.44End-of-day price as of Oct 9, 2026

Vir Biotechnology (VIR) closed at $585.35 on Oct 9, 2026, up 1.29% from the previous close of $577.91.

Share price, past year

1Y +26.91%

52-week range $461.22 – $614.28. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$585.35
Sep 30, 2026$568.77
Aug 31, 2026$552.08
Jul 31, 2026$586.85
Jun 30, 2026$597.91
May 29, 2026$571.81
Apr 30, 2026$564.28
Mar 31, 2026$535.95
Feb 27, 2026$537.13
Jan 30, 2026$548.84
Dec 31, 2025$522.77
Nov 28, 2025$519.18
Oct 31, 2025$493.29

Key statistics

Market cap
$99.03B
P/E (TTM)
—
EPS (TTM)
−$1.86
Revenue (TTM)
$303.23M
Net income (TTM)
−$251.68M
Shares outstanding
169.2M
Dividend yield
—
52-week range
$461.22 – $614.28

Vir Biotechnology's market cap is $99.03B, based on a share price of $585.35 and 169.2M shares outstanding as of Jun 30, 2026.

Financials

Vir Biotechnology reported revenue of $68.56M for fiscal 2025, down 7.61% from fiscal 2024.

Vir Biotechnology reported a net loss of $437.99M in fiscal 2025.

Annual revenue

FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
Vir Biotechnology annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$68.56M−7.6%−$437.99M−638.9%−$3.16−$396.61M
FY2024ended Dec 31, 2024$74.21M−13.9%−$521.96M−703.4%−$3.83−$453.65M
FY2023ended Dec 31, 2023$86.18M−94.7%−$615.06M−713.7%−$4.59−$800.36M
FY2022ended Dec 31, 2022$1.62B+47.5%$515.84M31.9%$3.83$1.60B
FY2021ended Dec 31, 2021$1.10B+1,334.4%$528.58M48.3%$3.96−$69.41M
FY2020ended Dec 31, 2020$76.37M+843.9%−$298.67M−391.1%−$2.51−$197.49M
FY2019ended Dec 31, 2019$8.09M−24.2%−$174.68M−2,159.0%−$5.76−$138.57M
FY2018ended Dec 31, 2018$10.67M+293.9%−$115.88M−1,086.3%−$15.12−$102.29M
FY2017ended Dec 31, 2017$2.71M—−$69.85M−2,579.5%−$32.45−$69.12M
Vir Biotechnology quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$238.95M$80.08M$0.47
Q1 FY2026ended Mar 31, 2026−$29.00K−$125.70M−$0.85
Q4 FY2025ended Dec 31, 2025$64.07M−$42.92M−$0.31
Q3 FY2025ended Sep 30, 2025$240.00K−$163.14M−$1.17
Q2 FY2025ended Jun 30, 2025$1.21M−$110.96M−$0.80
Q1 FY2025ended Mar 31, 2025$3.03M−$120.97M−$0.88
Q4 FY2024ended Dec 31, 2024$12.37M−$104.59M−$0.77
Q3 FY2024ended Sep 30, 2024$2.38M−$213.72M−$1.56

Company profile

Name
Vir Biotechnology, Inc.
Ticker
VIR
Exchange
NASDAQ
Industry (SEC SIC)
Biological Products, (No Diagnostic Substances)
Headquarters
1800 Owens Street, Suite 900, San Francisco, CA 94158
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0001706431

Recent SEC filings

Frequently asked questions

What is Vir Biotechnology's stock price?

Vir Biotechnology (VIR) closed at $585.35 on Oct 9, 2026, up 1.29% from the previous close of $577.91.

What is Vir Biotechnology's market cap?

Vir Biotechnology's market cap is $99.03B, based on a share price of $585.35 and 169.2M shares outstanding as of Jun 30, 2026.

How much revenue does Vir Biotechnology make?

Vir Biotechnology reported revenue of $68.56M for fiscal 2025, down 7.61% from fiscal 2024.

Does Vir Biotechnology pay a dividend?

Vir Biotechnology's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from Vir Biotechnology, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures